Intraocular pressure: Modulation as treatment for glaucoma

American Journal of Ophthalmology

Volumn 152, Issue 3, 2011, Pages 340-344.e2

  Caprioli, Joseph ^a   Varma, Rohit ^b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL; LATANOPROST; TIMOLOL;

ANTIHYPERTENSIVE THERAPY; ARGON LASER; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; EVENING DOSAGE; GLAUCOMA; HIGH RISK PATIENT; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NEUROPROTECTION; NONHUMAN; OPEN ANGLE GLAUCOMA; OPTIC NERVE INJURY; PATIENT IDENTIFICATION; PATIENT MONITORING; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RISK FACTOR; TRABECULOPLASTY;

EID: 80051912678     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.05.029     Document Type: Article

References (28)

1. D.M. Eddy, and J. Billings The Quality of Medical Evidence and Medical Practice Report Prepared for the National Leadership Committee on Health Care 1988
2. M.A. Kass, D.K. Heuer, and E.J. Higginbotham The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma Arch Ophthalmol 120 6 2002 701 713 (Pubitemid 34620348)
3. Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal tension glaucoma Am J Ophthalmol 126 4 1998 498 505
4. AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race Seven-year results Ophthalmology 105 7 1998 1146 1164
5. AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration Am J Ophthalmol 130 4 2000 429 440
6. A. Heijl, M.C. Leske, and B. Bengtsson Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial Arch Ophthalmol 120 10 2002 1268 1279 (Pubitemid 36105431)
7. D.C. Musch, B.W. Gillespie, P.R. Lichter, L.M. Niziol, N.K. Janz CIGTS Study Investigators Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors Ophthalmology 116 2 2009 200 207
8. B. Bergea, L. Bodin, and B. Svedbergh Impact of intraocular pressure regulation on visual fields in open-angle glaucoma Ophthalmology 106 5 1999 997 1004
9. W.C. Stewart, A.E. Kolker, and E.D. Sharpe Factors associated with long-term progression or stability in primary open-angle glaucoma Am J Ophthalmol 130 3 2000 274 279
10. C. O'Brien, B. Schwartz, T. Takamoto, and D.C. Wu Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma Am J Ophthalmol 111 4 1991 491 500
11. A.G. Konstas, G. Hollo, and Y.S. Astakhov Factors associated with long-term progression or stability in exfoliation glaucoma Arch Ophthalmol 122 1 2004 29 33 (Pubitemid 38063601)
12. K. Nouri-Mahdavi, D. Hoffman, and A.L. Coleman Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study Ophthalmology 111 9 2004 1627 1635 (Pubitemid 39179673)
13. J. Caprioli, and A.L. Coleman Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study Ophthalmology 115 7 2008 1123 1129
14. P.P. Lee, J.W. Walt, L.C. Rosenblatt, L.R. Siegartel, L.S. Stern Glaucoma Care Study Group Association between intraocular pressure variation and glaucoma progression: data from a United States chart review Am J Ophthalmol 144 6 2007 901 907
15. S. Hong, G.J. Seong, and Y.J. Hong Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure Arch Ophthalmol 125 8 2007 1010 1013 (Pubitemid 47258028)
16. D.C. Musch, B.W. Gillespie, L.M. Niziol, P.R. Lichter, R. Varma CIGTS Study Group Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study Ophthalmol 2011 Forthcoming
17. B. Bengtsson, M.C. Leske, L. Hyman, A. Heijl Early Manifest Glaucoma Trial Group Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial Ophthalmology 114 2 2007 205 209 (Pubitemid 46161799)
18. S. Miglior, N. Pfeiffer, V. Torri, T. Zeyen, J. Cunha-Vaz, I. Adamsons European Glaucoma Prevention Study (EGPS) Group Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study Ophthalmology 14 1 2007 3 9
19. F.A. Medeiros, R.N. Weinreb, and L.M. Zangwill Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma Ophthalmology 115 6 2008 934 940 (Pubitemid 351749687)
20. M.D. Roberts, V. Grau, and J. Grimm Remodeling of the connective tissue microarchitecture of the lamina cribrosa in early experimental glaucoma Invest Ophthalmol Vis Sci 50 2 2009 681 690
21. M.D. Roberts, Y. Liang, and I.A. Sigal Correlation between local stress and strain and lamina cribrosa connective tissue volume fraction in normal monkey eyes Invest Ophthalmol Vis Sci 51 1 2010 295 307
22. H. Kai, H. Kudo, N. Takayama, S. Yasuoka, H. Kajimoto, and T. Imaizumi Large blood pressure variability and hypertensive cardiac remodelingrole of cardiac inflammation Circ J 73 12 2009 2198 2203
23. P.M. Rothwell Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension Lancet 375 9718 2010 938 948
24. D.F. Su, and C.Y. Miao Reduction of blood pressure variability: a new strategy for the treatment of hypertension Trends Pharmacol Sci 26 8 2005 388 390
25. A.L. Coleman, and J. Caprioli The logic behind target intraocular pressure Am J Ophthalmol 147 3 2009 379 380
26. R. Varma, L.J. Hwang, J.W. Grunden, G.W. Bean, and M.B. Sultan Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range Am J Ophthalmol 148 2 2009 221 226
27. R. Varma, L. Hwang, J.W. Grunden, and G.W. Bean Inter-visit intraocular pressure range: an alternative parameter for assessing IOP control in clinical trials Am J Ophthalmol 145 2 2008 336 342
28. L.J. Katz, and J.S. Myers Smoothing the IOP roller coaster: a new goal? Am J Ophthalmol 148 2 2009 177 178